Two Specific Proteins Allow the Exclusion of IBD in Patients with Irritable Bowel Syndrome

Two Specific Proteins Allow the Exclusion of IBD in Patients with Irritable Bowel Syndrome
shutterstock_244122988A new study led by researchers at University of Michigan Health System recently analyzed the importance of several screening tests to exclude the diagnosis of inflammatory bowel disease (IBD) in patients with irritable bowel syndrome (IBS). The study was published in The American Journal of Gastroenterology and is entitled “A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS.” IBD corresponds to a chronic inflammatory condition of the digestive tract that primarily comprises ulcerative colitis and Crohn’s disease. It is characterized by vomiting, abdominal pain, rectal bleeding, diarrhea, internal cramps in the pelvis region, fatigue and weight loss. IBD can lead to life-threatening complications such as iron deficiency anemia. IBS is a chronic disorder that affects the colon (large intestine) and is characterized by abdominal pain, cramping, swelling, gas, diarrhea and constipation. Differ
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *